GUERBET
Guerbet SA engages in the research, development, production, and sale of contrast media products, delivery systems, medical devices, and related solutions worldwide. Its products for the CT and Cath Lab examinations include Optiray, a low osmolar contrast medium; Xenetix, a low-osmolar iodinated agent; Telebrix, a high osmolar contrast medium; Conray and MD high osmolar contrast medium products; and high osmolar contrast medium, an ionic low osmolar contrast medium agent. The company's products for the magnetic resonance imaging (MRI) examinations comprise Dotarem, a non-specific gadolinium-based contrast medium; Artirem products; and Optimark, a contrast medium. In addition, it provides products for interventional imaging, including Lipiodol ethyl esters of iodinated fatty acids of poppy seed oil; Vectorio, a classic transarterial chemoembolization mixing and injection system; and Patent Blue V, an injectable medium. Further, the company offers delivery systems and services comprising injectors; consumables for various types of injectors; and Contrast&Care, a patient data management software. The company distributes its products directly, as well as through distributors and license-holders primarily to hospitals, clinics, radiology centers, purchasing pools, and wholesalers. Guerbet SA was founded in 1926 and is headquartered in Villepinte, France. Show More...
-
Website http://www.guerbet.com
-
Sector Healthcare
-
Industry Medical Devices
-
Last Quote 20.15 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR 0.47 1.12 1.61 1.62 2.07 3.13 2.29 3.65 3.7 2.95 2.95 Dividends EUR 0.56 0.45 0.45 0.5 0.5 0.5 0.65 0.85 0.85 0.85 0.85 Payout Ratio % * 118.4 100.6 28.0 37.6 27.3 18.3 22.0 27.0 23.6 24.8 28.8 Shares Mil 12.0 13.0 13.0 13.0 13.0 13.0 13.0 13.0 13.0 13.0 13.0 Book Value Per Share * EUR 17.26 17.39 18.54 18.8 20.28 22.26 23.8 25.83 27.65 29.24 30.94 Free Cash Flow Per Share * EUR -0.27 -0.19 0.8 1.26 1.68 2.87 1.61 -1.58 1.78 2.48 Return on Assets % 1.44 3.31 4.48 4.45 5.59 5.81 3.0 4.66 4.6 3.57 3.57 Financial Leverage (Average) 2.0 2.09 2.04 1.93 1.84 3.17 3.27 2.79 2.95 2.59 2.59 Return on Equity % 2.83 6.78 9.25 8.82 10.51 14.71 9.67 14.07 13.21 9.88 9.88 Return on Invested Capital % 3.65 8.37 6.68 6.34 7.96 8.41 4.95 7.18 7.3 5.46 5.46 Interest Coverage 2.94 5.29 12.76 21.57 25.93 51.05 7.85 11.46 7.56 8.49 8.49 Current Ratio 1.95 1.65 1.66 1.69 1.67 1.89 1.91 2.12 1.35 2.39 2.39 Quick Ratio 0.89 0.73 0.74 0.75 0.75 0.83 0.88 1.04 0.67 1.19 1.19 Debt/Equity 0.3 0.26 0.17 1.06 1.05 0.84 0.53 0.88 0.88